Se încarcă compania
Just reported
Q3 2026 results
From Ensign's results release of 27 octombrie 2026; its quarterly report has since been filed.
Revenue
Actual
1,48B USD
+14 % y/y
+3,0 % q/qGuided
—
No guide given
EPS, GAAP
Actual
1,76 USD
+24 % y/y
+4,8 % q/qGuided
—
No guide given
Operating income, GAAP
Actual
138M USD
+43 % y/y
+13 % q/qGuided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Keep exploring
The themes Ensign is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The theme it is part of
Highest-graded in Medical Care Facilities
Graded A or B and worth $2B or more: A first, then the largest.
THCTenet Healthcare Corp.22,8B USDA+
EHCEncompass Health Corporation13,8B USDA+
PACSPACS Group, Inc.7,7B USDA
CONConcentra Group Holdings Parent, Inc.5,4B USDA
LFSTLifeStance Health Group, Inc.5,3B USDA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 oct. 2026CBGraded C, now B
MCKMckesson Corporation4 nov. 2026BAGraded B, now A
CVSCVS Health Corp4 nov. 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 nov. 2026BAGraded B, now A
GEHCGE Healthcare Technologies Inc.28 oct. 2026CAGraded C, now A
Situațiile financiare complete →
Construit din raportările proprii ale Ensign Group, Inc. la Comisia pentru Valori Mobiliare și Burse a SUA (SEC). Cifrele sunt cele raportate, iar istoricul pe acțiune este recalculat la baza de acțiuni de azi. Aceasta descrie o afacere — nu este consultanță de investiții și nu este o recomandare de cumpărare sau vânzare.
